Ocular Therapeutix, Inc. (OCUL)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:34AM EDT. Market open.
| Previous Close | 5.86 |
| Open | 5.90 |
| Bid | 4.25 x 200 |
| Ask | 6.37 x 200 |
| Day's Range | 4.98 - 5.90 |
| 52 Week Range | 2.00 - 11.31 |
| Volume | |
| Avg. Volume | 2,154,433 |
| Market Cap | 775.09M |
| Beta (5Y Monthly) | 1.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Down -17.88% in 4 Weeks, Here's Why Ocular Therapeutix (OCUL) Looks Ripe for a Turnaround
Ocular Therapeutix (OCUL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Thomson Reuters StreetEvents
Q4 2023 Clearside Biomedical Inc Earnings Call
Q4 2023 Clearside Biomedical Inc Earnings Call
- Zacks
Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 34.74%: Read This Before Placing a Bet
The consensus price target hints at a 34.7% upside potential for Ocular Therapeutix (OCUL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
© 2024 Yahoo. All rights reserved.